MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-11-0030711
Swapra Pharma Private Limited
Swapra Pharma Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹43.05 Lakh
▲ 329% YoY
Net profit · FY 2024
₹44,439
Net margin 1%
EBITDA · FY 2024
₹70,052
EBITDA margin 1.6%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1.04 Lakh
Issued & subscribed
Company age
30 yrs
Est. 1996
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Swapra Pharma Private Limited
Data last updated:
Swapra Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 January 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33119DL1996PTC075576. Its GSTIN is 07AAJCS4927Q1ZK (Delhi).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.04 Lakh. It is led by directors Gaurav Sharma and Mohan Lal Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. 11 G/F Magnum House 1st Commercial Complex Karampura, New Delhi, Delhi, India – 110015.
As per the financials filed for FY 2024, the company reported a revenue of ₹43.05 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹44,439 (net margin 1%) and EBITDA of ₹70,052 (EBITDA margin 1.6%). Revenue has grown at a compounded annual rate (CAGR) of 45% over three years and 18% over five years.
Swapra Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0030711).
Company details
CIN U33119DL1996PTC075576
Registration Number 075576
Incorporation Date 19 January 1996
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-DL-11-0030711
Key People
Gaurav Sharma Director Mohan Lal Sharma Director Recognitions & Rankings of Swapra Pharma
Contact details
Swapra Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No. 11 G/F Magnum House 1st Commercial Complex Karampura, New Delhi, Delhi, India – 110015
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Swapra Pharma Private Limited, buy the company report.
Comprehensive company report
Swapra Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Swapra Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Swapra Pharma Private Limited, buy the company report.
Financials of Swapra Pharma Private Limited
FY 2025 filings availableSwapra Pharma Private Limited reported revenue of ₹43.05 Lakh (up 329% YoY) for FY 2024.
Revenue · FY 2024
₹43.05 Lakh ▲ 329%
Net profit · FY 2024
₹44,439 margin 1%
EBITDA · FY 2024
₹70,052 margin 1.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 329%
3 years · compounded
▲ 45%
5 years · compounded
▲ 18%
EBITDA CAGR growth
1 year
▲ 304%
3 years · compounded
▲ 47%
5 years · compounded
▲ 4%
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 329% growth in the latest year. EBITDA rose 304% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹70,052 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹44,439 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.6% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Swapra Pharma Private Limited, buy the company report.
Board of directors of Swapra Pharma Private Limited
Swapra Pharma has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gaurav Sharma | Director | 30 Jan 2003 | 23 Years 9 Months | Current |
| Mohan Lal Sharma | Director | 01 Dec 2006 | 19 Years 11 Months | Current |
Peer comparison
Swapra Pharma Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ell Pee Medicare Private Limited | ₹43.34 Lakh (FY 2025) | 81.0% | Meerut, Uttar Pradesh, India | |||
| Medicon Ophthalmics Private Limited | ₹43.15 Lakh (FY 2021) | -36.0% | New Delhi, Delhi, India | |||
| Medistream Biotech Private Limited | ₹43.12 Lakh (FY 2025) | 11.0% | Vadodara, Gujarat, India | |||
| Amare Cor Pharmaceuticals Private Limited | ₹43.06 Lakh (FY 2024) | -4.0% | Ranchi, Jharkhand, India | |||
| Swapra Pharma Private Limitedthis company | ₹43.05 Lakh (FY 2024) | ₹44,439 | 1% | 329.0% | New Delhi, Delhi, India | |
| Hems & Nephews Exports Private Limited | ₹43 Lakh (FY 2024) | -34.0% | Chennai, Tamil Nadu, India | |||
| Vitaris Pharmaceutical Private Limited | ₹43 Lakh (FY 2025) | 38.0% | Aurangabad, Maharashtra, India | |||
| Arlics Pharmaceuticals Private Limited | ₹42.92 Lakh (FY 2025) | 1.0% | Mehsana, Gujarat, India | |||
| Straumann Dental India Private Limited | ₹42.92 Lakh (FY 2016) | 62.0% | Gurgaon, Haryana, India | |||
| Kiraat Pharmaceutical Private Limited | ₹42.89 Lakh (FY 2025) | 536.0% | Noida, Uttar Pradesh, India |
To see the full peer comparison of Swapra Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Swapra Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Swapra Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Swapra Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAJCS4927Q1ZK | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Swapra Pharma Private Limited, buy the company report.
Recent activity
Swapra Pharma Private Limited has 2 board changes on record since 2003: 2 appointments. The latest: Mohan Lal Sharma was appointed as Director on 01 Dec 2006.
AGM
Swapra Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Swapra Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Appointed
Mohan Lal Sharma was appointed as Director.
Appointed
Gaurav Sharma was appointed as Director.
Incorporation
19 Jan 1996
Swapra Pharma Private Limited was registered on 19 Jan 1996 with Roc Delhi Ii & aged 30 years 9 months as per MCA records.
Frequently asked questions
Swapra Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 January 1996 (30+ years old) and is registered under CIN U33119DL1996PTC075576.
Swapra Pharma has 2 current directors:
- Gaurav Sharma - Director
- Mohan Lal Sharma - Director
The latest financial statements of Swapra Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Swapra Pharma is 07AAJCS4927Q1ZK, registered in Delhi.
The CIN (Corporate Identification Number) of Swapra Pharma is U33119DL1996PTC075576. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Swapra Pharma was incorporated on 19 January 1996, making it 30+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Swapra Pharma by revenue are Ell Pee Medicare Private Limited, Medicon Ophthalmics Private Limited, Medistream Biotech Private Limited, Amare Cor Pharmaceuticals Private Limited, Hems & Nephews Exports Private Limited and 4 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Mohan Lal Sharma was appointed as Director on 01 Dec 2006. Gaurav Sharma was appointed as Director on 30 Jan 2003.
Yes, Swapra Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-11-0030711).
The registered office of Swapra Pharma is at Shop No. 11 GF Magnum House 1st Commercial Complex Karampura, New Delhi, Delhi, India – 110015.
Swapra Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages